Laboratorio Farmaceutico Erfo S.p.A. (BIT:ERFO)
Italy · Delayed Price · Currency is EUR 1.095
0.00 (0.00%)
Last updated: Jun 9, 2026, 4:55 PM CET
BIT:ERFO Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 0.74 | 0.35 | 0.59 | 0.72 | 1.17 |
Depreciation & Amortization | 0.77 | 0.69 | 0.72 | 0.62 | 0.44 |
Other Amortization | 0.15 | - | - | - | - |
Loss (Gain) From Sale of Investments | - | - | - | - | 0.01 |
Other Operating Activities | 0.18 | 0.04 | 0.05 | -0.03 | -0.03 |
Change in Accounts Receivable | -0.61 | 0.08 | -0.18 | -0.04 | -0.03 |
Change in Inventory | -0.45 | -0.01 | -0.05 | -0.29 | -0.01 |
Change in Accounts Payable | 0.38 | 0.03 | -0.06 | 0.33 | 0.02 |
Change in Other Net Operating Assets | -0.24 | 0.06 | 0.24 | -0.53 | 0.7 |
Operating Cash Flow | 0.92 | 1.24 | 1.3 | 0.76 | 2.27 |
Operating Cash Flow Growth | -25.97% | -4.32% | 70.25% | -66.49% | 64.27% |
Capital Expenditures | -0.07 | -0.07 | -0.31 | -0.46 | -0.18 |
Sale of Property, Plant & Equipment | - | - | - | 0.01 | - |
Sale (Purchase) of Intangibles | -2.5 | -0.45 | -1.13 | -0.72 | -0.07 |
Investment in Securities | 1.27 | -0.43 | 0.35 | -0.72 | -0.38 |
Other Investing Activities | 0 | - | -0 | - | - |
Investing Cash Flow | -1.29 | -0.95 | -1.1 | -1.88 | -0.62 |
Short-Term Debt Issued | 0.24 | 0.01 | 0 | - | 0.01 |
Long-Term Debt Issued | 1.08 | - | - | - | - |
Total Debt Issued | 1.31 | 0.01 | 0 | - | 0.01 |
Short-Term Debt Repaid | - | - | - | -0.03 | - |
Long-Term Debt Repaid | -0.35 | -0.09 | -0.12 | -0.13 | -0.04 |
Total Debt Repaid | -0.35 | -0.09 | -0.12 | -0.16 | -0.04 |
Net Debt Issued (Repaid) | 0.97 | -0.08 | -0.12 | -0.16 | -0.03 |
Issuance of Common Stock | 0.02 | - | - | 3 | - |
Repurchase of Common Stock | - | -0.12 | -0.44 | - | - |
Common Dividends Paid | - | -0.55 | -0.17 | -0.56 | -2.15 |
Other Financing Activities | 0.06 | -0 | -0.1 | -0.06 | - |
Financing Cash Flow | 1.05 | -0.76 | -0.82 | 2.22 | -2.18 |
Miscellaneous Cash Flow Adjustments | - | - | 0 | - | - |
Net Cash Flow | 0.68 | -0.47 | -0.63 | 1.1 | -0.53 |
Free Cash Flow | 0.85 | 1.17 | 0.98 | 0.3 | 2.1 |
Free Cash Flow Growth | -27.60% | 19.38% | 226.09% | -85.61% | 59.61% |
Free Cash Flow Margin | 8.74% | 19.46% | 16.58% | 6.39% | 41.87% |
Free Cash Flow Per Share | 0.10 | 0.14 | 0.11 | 0.03 | 1.40 |
Cash Income Tax Paid | 0.17 | 0.2 | 0.21 | 0.31 | 0.43 |
Levered Free Cash Flow | -1.6 | 0.87 | -0.24 | -1.25 | 1.95 |
Unlevered Free Cash Flow | -1.56 | 0.88 | -0.22 | -1.22 | 1.96 |
Change in Working Capital | -0.91 | 0.16 | -0.06 | -0.54 | 0.68 |